Clarity Science is a leading international scientific research organization that performs rigorous research in the field of healthcare across a myriad of therapeutic specialties.
We conduct institutional review board (IRB)-approved clinical research studies with the utmost integrity– adhering to the highest standards of scientific excellence. Under the guidance of leading physicians, board-certified healthcare attorneys, and expert statisticians, our studies are producing reliable, informative outcomes. Our research has been well-received by healthcare providers and continues to be recognized at major national and international conferences.
Our goal is to conduct research that advances innovation in science and ultimately helps healthcare professionals provide treatments and improved patient care.
See informative results from our studies.
Current Scar Study
(TopicAl Silicone in RestorinG Scars and Burn Tissue – Evaluating Therapy)
Positive interim TARGET Results have been presented at leading conferences, including the 7th Joint Meeting of the European Tissue Repair Society & the Wound Healing Society held in Copenhagen, Denmark, among others.
Results from an interim analysis of our TARGET study (a scar and burn treatment study) show that adults using a prescribed topical scar and burn cream reported:
Reduced scar/burn size as measured by clinicians and as perceived by patients.
Reduced scar/burn interference with general activity, mood, sleep, and life enjoyment.
Reduced pain medication use.
Closed Pain Study
(Optimizing Patient Experience and Response to Topical Analgesics)
Positive interim OPERA Results have been presented at important conferences, including the 4th Annual International Conference on Opioids held at Harvard Medical School, among others.
Results from an interim analysis of our OPERA study (a pain study) show that patients with musculoskeletal and neuropathic pain using a prescribed topical analgesic reported:
Reduced pain severity for patients with neuropathic and musculoskeletal pain.
Reduced pain interference with general activity, mood, sleep, and life enjoyment.
Reduced number of primary pain complaints for arthritis, neuropathy, or radiculopathy.
Reduced use of over-the-counter medications, anti-inflammatory medications, and opioid analgesics.
Clarity presented statistically-significant interim data from our OPERA study, a pain management study.
Clarity presented data from our TARGET Study at APWCA.
Clarity was awarded First Place for Best Scientific Presentation/Data.
Clarity will present interim data from our OPERA study, a pain management study.
Clarity to Exhibit at AAAAI
November 2, 2015
TARGET Study Data to be Presented at APWCA
February 25, 2016
NIH Study Invitation
November 1, 2015
TARGET Study featured in the Journal of Wound Technology
January 5, 2016